Molecular Partners Ag (MOLN) Receivables - Net (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Receivables - Net for 7 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Net fell 61.04% year-over-year to $1.7 million in Q2 2026; TTM through Jun 2026 was $1.7 million, a 61.04% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 16.01% from the prior year.
• Receivables - Net was $1.7 million for Q2 2026 at Molecular Partners Ag, down from $3.0 million in the prior quarter.
• Over five years, Receivables - Net peaked at $20.7 million in Q2 2023 and troughed at $1.1 million in Q4 2022.
• A 5-year average of $5.7 million and a median of $2.8 million in 2024 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net tumbled 96.2% in 2022 and surged 108.15% in 2023, its largest moves.
• Over 5 years, Receivables - Net stood at $1.1 million in 2022, then surged by 108.15% to $2.2 million in 2023, then grew by 20.13% to $2.6 million in 2024, then declined by 13.24% to $2.3 million in 2025, then slipped by 26.06% to $1.7 million in 2026.
• The last three Receivables - Net figures came in at $1.7 million (Q2 2026), $3.0 million (Q1 2026), and $2.3 million (Q4 2025), per Business Quant data.